These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 31804402)
41. Pancreatic desmoid-type fibromatosis with beta-catenin gene mutation-Report of a case and review of the literature. Tsukamoto Y; Imakita M; Nishitani A; Ito T; Izukura M; Hirota S Pathol Res Pract; 2016 May; 212(5):484-9. PubMed ID: 26907785 [TBL] [Abstract][Full Text] [Related]
44. Clinical significance of midkine expression in sporadic desmoid tumors. Kim HS; Kim J; Nam KH; Kim WH Oncol Lett; 2016 Mar; 11(3):1677-1684. PubMed ID: 26998061 [TBL] [Abstract][Full Text] [Related]
45. A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates. Mercier KA; Al-Jazrawe M; Poon R; Acuff Z; Alman B Sci Rep; 2018 Jan; 8(1):584. PubMed ID: 29330550 [TBL] [Abstract][Full Text] [Related]
46. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Le Guellec S; Soubeyran I; Rochaix P; Filleron T; Neuville A; Hostein I; Coindre JM Mod Pathol; 2012 Dec; 25(12):1551-8. PubMed ID: 22766794 [TBL] [Abstract][Full Text] [Related]
47. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. Huss S; Nehles J; Binot E; Wardelmann E; Mittler J; Kleine MA; Künstlinger H; Hartmann W; Hohenberger P; Merkelbach-Bruse S; Buettner R; Schildhaus HU Histopathology; 2013 Jan; 62(2):294-304. PubMed ID: 23020601 [TBL] [Abstract][Full Text] [Related]
48. High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management. Dômont J; Salas S; Lacroix L; Brouste V; Saulnier P; Terrier P; Ranchère D; Neuville A; Leroux A; Guillou L; Sciot R; Collin F; Dufresne A; Blay JY; Le Cesne A; Coindre JM; Bonvalot S; Bénard J Br J Cancer; 2010 Mar; 102(6):1032-6. PubMed ID: 20197769 [TBL] [Abstract][Full Text] [Related]
49. Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis. Colombo C; Urbini M; Astolfi A; Collini P; Indio V; Belfiore A; Paielli N; Perrone F; Tarantino G; Palassini E; Fiore M; Pession A; Stacchiotti S; Pantaleo MA; Gronchi A Genes Chromosomes Cancer; 2018 Oct; 57(10):495-503. PubMed ID: 29901254 [TBL] [Abstract][Full Text] [Related]
50. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. Crago AM; Chmielecki J; Rosenberg M; O'Connor R; Byrne C; Wilder FG; Thorn K; Agius P; Kuk D; Socci ND; Qin LX; Meyerson M; Hameed M; Singer S Genes Chromosomes Cancer; 2015 Oct; 54(10):606-15. PubMed ID: 26171757 [TBL] [Abstract][Full Text] [Related]
51. Desmoid Fibromatosis With TP53 Mutation and Striking Nuclear Pleomorphism. Foster CR; Strauss M; Hornick JL; Habeeb O Int J Surg Pathol; 2023 Dec; 31(8):1565-1571. PubMed ID: 36908221 [TBL] [Abstract][Full Text] [Related]
52. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184 [TBL] [Abstract][Full Text] [Related]
53. Intra-abdominal desmoid fibromatosis mimicking tumour recurrence after the operation: A case series. Nam KH; Kim B Malays J Pathol; 2023 Apr; 45(1):111-122. PubMed ID: 37119251 [TBL] [Abstract][Full Text] [Related]
54. Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours. Kattentidt Mouravieva AA; Geurts-Giele IR; de Krijger RR; van Noesel MM; van de Ven CP; van den Ouweland AM; Kromosoeto JN; Dinjens WN; Dubbink HJ; Smits R; Wagner A Eur J Cancer; 2012 Aug; 48(12):1867-74. PubMed ID: 22305464 [TBL] [Abstract][Full Text] [Related]
55. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study. Nathenson MJ; Hu J; Ratan R; Somaiah N; Hsu R; DeMaria PJ; Catoe HW; Pang A; Subhawong TK; Amini B; Sweet K; Feister K; Malik K; Jagannathan J; Braschi-Amirfarzan M; Sheren J; Caldas Y; Moreno Tellez C; Rosenberg AE; Lazar AJ; Maki RG; Benedetto P; Cohen J; Trent JC; Ravi V; Patel S; Wilky BA Clin Cancer Res; 2022 Sep; 28(18):4092-4104. PubMed ID: 35180772 [TBL] [Abstract][Full Text] [Related]
56. Adipocyte-rich Bakker A; Slack JC; Caragea M; Kurek KC; Bründler MA Pediatr Dev Pathol; 2021; 24(1):62-67. PubMed ID: 33104413 [TBL] [Abstract][Full Text] [Related]
57. Cutaneous desmoid-type fibromatosis: A rare case with molecular profiling. Aghighi M; Cloutier JM; Hoover WD; Roy K; Lo AA; Brown RA J Cutan Pathol; 2021 Sep; 48(9):1185-1188. PubMed ID: 33978242 [TBL] [Abstract][Full Text] [Related]
58. Sporadic desmoid tumors in the pediatric population: A single center experience and review of the literature. Shkalim Zemer V; Toledano H; Kornreich L; Freud E; Atar E; Avigad S; Feinberg-Gorenshtein G; Fichman S; Issakov J; Dujovny T; Yaniv I; Ash S J Pediatr Surg; 2017 Oct; 52(10):1637-1641. PubMed ID: 28209418 [TBL] [Abstract][Full Text] [Related]
59. Clinical application of next-generation sequencing for the management of desmoid tumors: A case report and literature review. Lee JM; Kim HG; Shin SY; Lee SH Medicine (Baltimore); 2021 Jan; 100(1):e24238. PubMed ID: 33429825 [TBL] [Abstract][Full Text] [Related]
60. A rare cause of small bowel obstruction caused by duodenum-derived aggressive fibromatosis with β-catenin T41A mutation: A case analysis. Zhao D; Wang X Medicine (Baltimore); 2024 Jul; 103(28):e38984. PubMed ID: 38996097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]